Rallybio Corp Contracts & Agreements
36 Contracts & Agreements
- Business Finance (14 contracts)
- Business Operations (3)
- Human Resources (11)
- Intellectual Property (4)
- Uncategorized (4)
- Registration Rights Agreement, dated April 10, 2024, by and between Rallybio Corporation and Johnson & Johnson Innovation - JJDC, Inc (Filed With SEC on August 8, 2024)
- Securities Purchase Agreement, dated April 10, 2024, by and between Rallybio Corporation and Johnson & Johnson Innovation - JJDC, Inc (Filed With SEC on August 8, 2024)
- FNAIT Collaboration Agreement, dated April 9, 2024, by and between Momenta Pharmaceuticals, Inc. and Rallybio IPA, LLC (Filed With SEC on August 8, 2024)
- Form of Consulting Agreement (Filed With SEC on July 23, 2024)
- Underwriting Agreement, dated November 10, 2022, by and among the Company and J.P. Morgan Securities LLC, Cowen and Company, LLC and Evercore Group L.L.C., as representatives of... (Filed With SEC on November 14, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on November 14, 2022)
- License Agreement by and between Rallybio IPE, LLC and Kymab Limited, dated as of May 5, 2022 (Filed With SEC on August 8, 2022)
- Description of Registrants Securities (Filed With SEC on March 15, 2022)
- Registration Rights Agreement, dated July 28, 2021, among the Registrant and certain of its stockholders (Filed With SEC on August 2, 2021)
- Form of Underwriting Agreement (Filed With SEC on July 22, 2021)
- Form of Plan of Liquidation and Dissolution (Filed With SEC on July 22, 2021)
- Specimen stock certificate evidencing shares of common stock (Filed With SEC on July 22, 2021)
- Form of Registration Rights Agreement, among the Registrant and certain of its stockholders, to be in effect immediately prior to completion of this offering (Filed With SEC on July 22, 2021)
- Form of Indemnification Agreement, between the Registrant and each of its directors and executive officers (Filed With SEC on July 22, 2021)
- Form of Restricted Share Agreement (Capital Interests) under the Rallybio Holdings, LLC 2018 Share Plan (Filed With SEC on July 22, 2021)
- Form of Restricted Share Agreement (Profits Interests) under the Rallybio Holdings, LLC 2018 Share Plan (Filed With SEC on July 22, 2021)
- Form of Contribution and Restricted Share Agreement (Filed With SEC on July 22, 2021)
- Rallybio Corporation 2021 Equity Incentive Plan (Filed With SEC on July 22, 2021)
- Form of Non-Qualified Stock Option Award Agreement under the Rallybio Corporation 2021 Equity Incentive Plan (Filed With SEC on July 22, 2021)
- Form of Non-Qualified Stock Option Award Agreement for Non-Employee Directors under the Rallybio Corporation 2021 Equity Incentive Plan (Filed With SEC on July 22, 2021)
- Form of Incentive Stock Option Award Agreement under the Rallybio Corporation 2021 Equity Incentive Plan (Filed With SEC on July 22, 2021)
- Form of Restricted Stock Unit Award Agreement under the Rallybio Corporation 2021 Equity Incentive Plan (Filed With SEC on July 22, 2021)
- Form of Restricted Stock Unit Award Agreement for Non-Employee Directors under the Rallybio Corporation 2021 Equity Incentive Plan (Filed With SEC on July 22, 2021)
- Rallybio Corporation 2021 Cash Incentive Plan (Filed With SEC on July 22, 2021)
- Rallybio Corporation 2021 Employee Stock Purchase Plan (Filed With SEC on July 22, 2021)
- Amended and Restated Employment Agreement between Rallybio, LLC and Martin Mackay (Filed With SEC on July 22, 2021)
- Amended and Restated Employment Agreement between Rallybio, LLC and Stephen Uden (Filed With SEC on July 22, 2021)
- Amended and Restated Employment Agreement between Rallybio, LLC and Jeffrey M. Fryer (Filed With SEC on July 22, 2021)
- Form of Equity Adjustment Notice (Filed With SEC on July 22, 2021)
- Asset Purchase Agreement, by and between Rallybio IPA, LLC and Prophylix AS, dated June 28, 2019 (Filed With SEC on July 2, 2021)
- Asset Transfer Agreement, by and between Swedish Orphan Biovitrum AB (PUBL) and IPC Research, LLC, dated March 15, 2019 (Filed With SEC on July 2, 2021)
- Product License Agreement, by and between Affibody AB and Swedish Orphan Biovitrum AB (PUBL), dated March 9, 2012, and assigned to IPC Research, LLC on March 15, 2019 (Filed With SEC on July 2, 2021)
- Amendment No. 1 to Product License Agreement, by and between Affibody AB and Swedish Orphan Biovitrum AB (PUBL), dated January 1, 2018, and assigned to IPC Research, LLC on March... (Filed With SEC on July 2, 2021)
- Amendment No. 2 to Product License Agreement, by and between Affibody AB and IPC Research, LLC, dated December 22, 2020 (Filed With SEC on July 2, 2021)
- Operating Agreement of RE Ventures I, LLC, by and between Rallybio IPB, LLC and Exscientia Limited, dated July 19, 2019 (Filed With SEC on July 2, 2021)
- Rallybio Holdings, LLC 2018 Share Plan, as amended (Filed With SEC on July 2, 2021)
